FindTrial
Sign In

Pan-cancer research and innovative drugs

Pan-cancer research and innovative drugs

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500106585
Enrollment
Unknown
Registered
2025-07-25
Start date
2025-08-01
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Interventions

Observation group:noting

Sponsors

Peking University First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Patients diagnosed with reproductive system tumors, respiratory system tumors, nervous system tumors, skin system tumors, endocrine system tumors or musculoskeletal system tumors and who will undergo surgical removal. Age: 18-80, gender not limited.

Exclusion criteria

Exclusion criteria: 1.Patients who have not been diagnosed with reproductive system tumors, respiratory system tumors, nervous system tumors, skin system tumors, endocrine system tumors or musculoskeletal system tumors and will undergo surgical removal. The age is not between 18 and 80.

Design outcomes

Primary

MeasureTime frame
Gene expression level;—

Countries

China

Contacts

Public ContactZhang Ning

Peking University First Hospital

zhangning@bjmu.edu.cn+86 10 83575851

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026